NIAGEN BIOSCIENCE, INC. (NAGE) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $79.00K; Additional Paid in CapitalUSD $239.70M; Retained Earnings (Accumulated Deficit)USD $-157.25M; Stockholders' Equity Attributable to ParentUSD $82.53M.
- 2026-03-31: Common Stock, Value, IssuedUSD $79.00K; Additional Paid in CapitalUSD $240.46M; Retained Earnings (Accumulated Deficit)USD $-158.21M; Stockholders' Equity Attributable to ParentUSD $82.33M.
- 2025-12-31: Common Stock, Value, IssuedUSD $79.00K; Additional Paid in CapitalUSD $240.99M; Retained Earnings (Accumulated Deficit)USD $-164.53M; Stockholders' Equity Attributable to ParentUSD $76.53M.
- 2025-09-30: Common Stock, Value, IssuedUSD $79.00K; Additional Paid in CapitalUSD $239.27M; Retained Earnings (Accumulated Deficit)USD $-168.66M; Stockholders' Equity Attributable to ParentUSD $70.68M.
NIAGEN BIOSCIENCE, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Partners' Capital Account, Units, Sold in Private Placement shares | Partners' Capital Account, Public Sale of Units Net of Offering Costs USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $79.00K | $239.70M | $-157.25M | $82.53M | 3 month · $2.77M 6 month · $5.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $79.00K | $240.46M | $-158.21M | $82.33M | 3 month · $2.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $79.00K | $240.99M | $-164.53M | $76.53M | 12 month · $251.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $79.00K | $239.27M | $-168.66M | $70.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $79.00K | $237.36M | $-173.24M | $64.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $78.00K | $232.12M | $-176.85M | $55.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $77.00K | $227.93M | $-181.91M | $46.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $76.00K | $223.39M | $-189.09M | $34.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $75.00K | $221.61M | $-190.97M | $30.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $75.00K | $219.83M | $-190.95M | $28.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $75.00K | $218.84M | $-190.46M | $28.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $75.00K | $217.81M | $-190.57M | $27.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $75.00K | $216.69M | $-189.62M | $27.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $74.00K | $215.37M | $-187.42M | $28.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $74.00K | $214.09M | $-185.49M | $28.67M | (m) | 12 month · $400.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $68.00K | $205.03M | $-184.07M | $21.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $68.00K | $203.80M | $-183.09M | $20.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $68.00K | $202.50M | $-176.69M | $25.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $68.00K | $200.61M | $-168.95M | $31.73M | (m) | 12 month · $400.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $68.00K | $199.01M | $-163.63M | $35.45M | (m) | 9 month · $400.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $68.00K | $196.85M | $-154.77M | $42.14M | (m) | 3 month · $300.00K 6 month · $400.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $68.00K | $192.97M | $-149.21M | $43.83M | (m) | 3 month · $100.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $62.00K | $158.19M | $-141.82M | $16.42M | (m) | 12 month · $100.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $62.00K | $155.16M | $-135.73M | $19.49M | (m) | 9 month · $100.00K | 3 month · $1.57M 9 month · $5.16M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $61.00K | $153.04M | $-131.51M | $21.58M | (m) | 3 month · $100.00K 6 month · $100.00K | 3 month · $1.71M 6 month · $3.58M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $60.00K | $144.29M | $-127.80M | $16.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $60.00K | $142.28M | $-121.90M | $20.45M | (m) | (m) | (m) | (m) | (m) | 12 month · $281.00K | (m) | (m) |
| 2019-09-30 | $59.00K | $140.13M | $-113.05M | $27.14M | (m) | (m) | 3 month · $1.69M | (m) | (m) | 3 month · $282.00K 9 month · $282.00K | (m) | (m) |
| 2019-06-30 | $55.00K | $120.94M | $-105.84M | $15.14M | (m) | (m) | 3 month · $1.76M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $55.00K | $119.01M | $-98.09M | $20.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $55.00K | $116.88M | $-89.75M | $27.18M | (m) | (m) | (m) | 12 month · $164.00M | (m) | (m) | (m) | (m) |
| 2018-09-30 | $55.00K | $114.88M | $-81.53M | $33.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $55.00K | $113.38M | $-72.93M | $40.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $55.00K | $111.49M | $-64.88M | $46.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-30 | $55.00K | $110.38M | $-56.60M | $53.83M | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) |
| 2017-09-30 | $47.65K | $81.47M | $-47.78M | $33.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-07-01 | $45.57K | $75.59M | $-49.92M | $25.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-04-01 | $37.92K | $56.49M | $-47.15M | $9.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $37.55K | $55.16M | $-45.22M | $9.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-10-01 | $37.54K | $54.90M | $-43.08M | $11.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-07-02 | $37.49K | $54.53M | $-42.12M | $12.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $10.00K |
| 2016-06-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 117.02K | (m) |
| 2016-04-02 | $36.18K | $48.43M | $-42.04M | $6.43M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $20.00K |
| 2016-03-11 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 128.21K | (m) |
| 2016-01-02 | $36.00K | $47.53M | $-42.30M | $5.27M | (m) | (m) | (m) | (m) | 12 month · $1.97M | (m) | (m) | (m) |
| 2015-10-03 | $106.32K | $45.10M | $-40.87M | $4.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-07-04 | $106.29K | $44.66M | $-40.87M | $3.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-04-04 | $105.99K | $44.13M | $-40.55M | $3.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-01-03 | $105.27K | $43.42M | $-39.52M | $4.00M | (m) | (m) | (m) | (m) | 12 month · $246.19K | (m) | (m) | (m) |
| 2014-09-27 | $105.24K | $42.70M | $-38.30M | $4.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-28 | $104.72K | $41.85M | $-37.64M | $4.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-29 | $104.56K | $40.67M | $-35.98M | $4.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-28 | $104.53K | $39.70M | $-34.14M | $5.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-28 | $100.82K | $36.58M | $-33.41M | $3.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-29 | $100.81K | $36.33M | $-32.16M | $4.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-30 | $96.01K | $34.89M | $-31.14M | $3.84M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-29 | $92.14K | $33.62M | $-29.72M | $3.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-29 | $91.65K | $33.16M | $-28.02M | $5.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $90.31K | $31.99M | $-26.48M | $5.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $88.20K | $30.66M | $-22.49M | $8.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $72.94K | $20.54M | $-18.05M | $2.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-10-01 | $72.94K | $20.04M | $-15.56M | $4.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-02 | $65.72K | $17.57M | $-13.16M | $4.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-02 | (m) | (m) | (m) | $5.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-01-01 | $60.88K | $15.03M | $-10.16M | $4.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-01-02 | (m) | (m) | (m) | $1.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |